Skip to main content
Log in

The antigenicity of whole virus versus subunit trivalent influenza vaccines — a field trial in the Israel Defence Forces, 1978

  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

A single dose of a commercial trivalent influenza subunit vaccine (SV) and two whole virus vaccines (WVV) were compared in a randomized, placebo-controlled field trial of subjects under 23 years of age in the Israel Defence Forces. Sixty percent of SV recipients and 29% and 37% of WVV recipients showed no measurable response to the H1N1 subtype (A/USSR). When the prevaccination titer to H1N1 was <10, SV did not differ significantly from the placebo, and when ⩾10, the SV was poorer than the WVV. Response to the H3N2 (A/Texas) component was excellent, but when the prevaccination titer was <10, SV appeared less immunogenic than WVV. All three vaccines performed equally against the B/Hong Kong strain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Influenza vaccines for 1978–9 (1978) BMJ: 1237

  2. U.S. Public Health Service (1978) Recommendation of the Public Health Service Advisory Committee on Immunization Practices Influenza vaccine. MMWR 32:285–286, 291–292

    Google Scholar 

  3. Parkman PD, Galasso GT, Top FH, Noble GR (1976) Summary of clinical trials of influenza vaccines. J Infect Dis 134:100–107

    Google Scholar 

  4. U.S. Public Health Service, Department of Health, Education and Welfare (1975) Advanced laboratory techniques for influenza vaccines. Immunology Ser 6

  5. Feery BJ, Hampson AW, Forsyth JRL, Evered MG (1977) Effect of dose on antibody response to subunit influenza vaccine. Med J Aust 2:324–327

    PubMed  Google Scholar 

  6. Webster RG, Kasel JA, Couch RB, Laver WG (1976) Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in Humans. J Infect Dis 134: 48–58

    PubMed  Google Scholar 

  7. U.S. Department of Health, Education and Welfare (1976) Influenza vaccine — supplemental statement. Recommendation of the Public Health Service Advisory Committee on Immunization Practices. MMWR 25:221–222

    Google Scholar 

  8. Ortbals DW, Liebhaber H (1978) Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults. J Clin Microbiol 8:431–434

    PubMed  Google Scholar 

  9. McLaren C, Grubbs GE, Staton E, Barthlow W, Quinnan G, Ennis FA (1980) Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice. Infect Immun 28:171–177

    PubMed  Google Scholar 

  10. Nicholson KG, Tyrrell DAJ, Harrison P, Potter CW, Jennings R, Clark A, Schild GC, Wood JM, Yetts R, Seagroatt V, Huggins A, Anderson SG (1979) Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand 7:123–136

    PubMed  Google Scholar 

  11. Pyhala R, Aho K (1975) Serum HI antibody and protection against influenza: a follow-up survey at community level of three epidemics caused by different H3N2 variants. Int J Epidemiol 4:127–129

    PubMed  Google Scholar 

  12. Delem A, Jovanovic D (1978) Correlation between rate of infection and preexisting titer of serum antibody as determined by single radial hemolysis during an epidemic of influenza A/Victoria/3/75. J Infect Dis 137:194–196

    PubMed  Google Scholar 

  13. Lebiush M, Rannon L, Kark JD (in press) An outbreak of A/USSR/90/77 (H1N1) influenza in army recruits — clinical and laboratory observations. Military Med

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kark, J.D., Lebiush, M., Rannon, L. et al. The antigenicity of whole virus versus subunit trivalent influenza vaccines — a field trial in the Israel Defence Forces, 1978. Med Microbiol Immunol 170, 55–62 (1981). https://doi.org/10.1007/BF02123797

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02123797

Keywords

Navigation